Viewing Study NCT02905851


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-01-01 @ 12:47 AM
Study NCT ID: NCT02905851
Status: COMPLETED
Last Update Posted: 2018-07-02
First Post: 2016-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris
Sponsor: University of California, Davis
Organization:

Study Overview

Official Title: Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris
Status: COMPLETED
Status Verified Date: 2018-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To see if teledermatology can be used to reduce antibiotic burden in patients on doxycycline or minocycline for acne vulgaris
Detailed Description: The investigators are going to ascertain if antibiotic burden can be reduced with tele dermatology use.

There are two arms of the study:

1. Feedback group
2. Non feedback group

All subjects will be randomised to either group, all subjects will take photos of their face and answer questions at baseline, visit 2 (1 month), visit 3 (2 months), visit 4 (3 months).

The investigators will then use measurements of acne grading (patient grading, investigator global assessment, lesion counting, global acne grading) to reduce/taper antibiotics in the feedback group.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: